Results: 17

Transición en enfermedades inflamatorias intestinales: de la pediatría a la adultez

Med. infant; 31 (2), 2024
El 25% de los pacientes con Enfermedades Inflamatorias Intestinales (EII) se diagnostican antes de los 20 años. En la mayor parte de los centros del país se lleva a cabo la “transferencia” del paciente desde un centro de atención pediátrico a uno de adultos. La “transición” es un criterio de...

Brechas de acceso en el manejo y tratamiento en Enfermedad Inflamatoria Intestinal

Gastroenterol. latinoam; 35 (2), 2024
Social determinants of health can mean difficulties in access to diagnosis, management and adequate treatment of IBD. Income, educational level, age, sex, and rurality, among other factors, can influence the health outcomes of specific populations, such as IBD patients. It is essential to be aware of the...

Therapeutic drug monitoring in inflammatory bowel disease

Inflammatory bowel disease (IBD) is a problem that directly affects the quality of life of patients suffering from this condition. Monitoring the serum level of infliximab (IFX) (TDM) is an important tool for guiding therapeutic decisions in IBD patients. The purpose of this study was to determine the si...

Current treatment strategies for inflammatory bowel disease patients at the risk of developing cancer: a comprehensive review

Inflammatory bowel disease (IBD) is a chronic condition that affects the digestive tract and can lead to inflammation and damage to the intestinal lining. IBD patients with cancer encounter difficulties since cancer treatment weakens their immune systems. A multidisciplinary strategy that strikes a balan...

Atendimento da doença inflamatória intestinal no Brasil: como é feito, os entraves e as demandas sob a ótica dos médicos

Arq. gastroenterol; 57 (4), 2020
ABSTRACT BACKGROUND: Inflammatory bowel diseases (IBD) are chronic inflammatory affections of recurrent nature whose incidence and prevalence rates have increased, including in Brazil. In long term, they are responsible for structural damage that impacts quality of life, morbidity and mortality of pati...

Embarazo en enfermedad inflamatoria intestinal: no solo 9 meses de cuidado

Rev. méd. Chile; 148 (12), 2020
The prevalence of inflammatory bowel disease (IBD) increased in the last decades. Thus, the number of pregnant women with the condition is also increasing. Given that active disease itself is the main risk factor for complications during pregnancy, it is necessary to achieve a complete remission before p...

Inflammatory Bowel Diseases and diet: an integrative review

SUMMARY OBJECTIVE: To gather scientific evidence on the role of diet in inflammatory bowel diseases. METHODS: Integrative review with studies published in the last 10 years in national and international journals. Original studies developed with adult human beings aged ≥18 years were included and ...

Recomendaciones para el manejo de pacientes con enfermedad Inflamatoria Intestinal (EII) y COVID-19

Gastroenterol. latinoam; 31 (1), 2020
The new Coronavirus (SARS-CoV-2) appeared in China in December 2019. Since then and until April 2020 it spread worldwide affecting more than three million people. Its exponential rise is still growing all over the world, taking thousands of lives. SARS-CoV-2 is very contagious, person to person, by dropl...